SCHEMBL4649015

SCHEMBL4649015

O=C(O)C(=COC(F)(F)F)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 3/20 0.48
CES1 P23141 3/20 0.44
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 3/20 0.41
CES2 O00748 2/20 0.40
ALDH1A1 P00352 3/20 0.40
AKR1C3 P42330 2/20 0.39
AKR1C2 P52895 2/20 0.39
PTGS2 P35354 1/20 0.38
F2 P00734 1/20 0.38
LMNA P02545 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
DAO P14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7149428 0.86 CES1 (0.41) AKR1C1CES1KMT2APOLBCES2
SCHEMBL28907328 0.83 AKR1C1 (0.36) AKR1C1CES1KMT2AMEN1POLB
SCHEMBL4725825 0.80 AAK1 (0.42) AKR1C1CES1KMT2ACES2ALDH1A1
SCHEMBL6722688 0.79 CES1 (0.43) AKR1C1CES1CES2ALDH1A1F2
SCHEMBL17311137 0.77 AKR1C1 (0.44) AKR1C1CES1KMT2AMEN1POLB
SCHEMBL15579004 0.75 AKR1C1 (0.53) AKR1C1CES1KMT2AMEN1POLB
SCHEMBL1996920 0.75 AKR1C1 (0.53) AKR1C1CES1KMT2AMEN1POLB
SCHEMBL9405147 0.75 AKR1C1 (0.53) AKR1C1CES1KMT2AMEN1POLB
SCHEMBL2407093 0.75 AKR1C1 (0.53) AKR1C1CES1KMT2AMEN1POLB
SCHEMBL7146890 0.75 AKR1C1 (0.53) AKR1C1CES1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948623-A2 HETEROCYCLIC AMIDE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES Janssen Pharmaceutica, N.V. (BE) 2008-07-30 EP disclosed
WO-2007041077-A2 HETEROCYCLIC AMIDE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-12 WO disclosed
EP-1309590-A1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2003-05-14 EP disclosed
WO-2001098299-A1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2001-12-27 WO disclosed